Arcturus Therapeutics Holdings (ARCT) Change in Account Payables (2018 - 2025)
Historic Change in Account Payables for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to -$5.0 million.
- Arcturus Therapeutics Holdings' Change in Account Payables fell 3367.78% to -$5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 million, marking a year-over-year increase of 4224.28%. This contributed to the annual value of $1.9 million for FY2024, which is 18556.75% up from last year.
- Latest data reveals that Arcturus Therapeutics Holdings reported Change in Account Payables of -$5.0 million as of Q3 2025, which was down 3367.78% from $4.4 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' Change in Account Payables' 5-year high stood at $11.8 million during Q1 2023, with a 5-year trough of -$12.7 million in Q4 2023.
- Its 5-year average for Change in Account Payables is -$306315.8, with a median of -$1.0 million in 2025.
- Per our database at Business Quant, Arcturus Therapeutics Holdings' Change in Account Payables crashed by 56927.78% in 2022 and then soared by 2689090.91% in 2023.
- Over the past 5 years, Arcturus Therapeutics Holdings' Change in Account Payables (Quarter) stood at $1.8 million in 2021, then plummeted by 569.28% to -$8.4 million in 2022, then plummeted by 50.76% to -$12.7 million in 2023, then skyrocketed by 76.94% to -$2.9 million in 2024, then tumbled by 71.77% to -$5.0 million in 2025.
- Its Change in Account Payables was -$5.0 million in Q3 2025, compared to $4.4 million in Q2 2025 and -$1.0 million in Q1 2025.